1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Blood and immune system conditions
  5. Allergies

Benralizumab for treating eosinophilic oesophagitis in people aged 12 to 65 [ID5093]

Discontinued [GID-TA10995]

  • Project information
  • Project documents

29739-Benralizumab-for-Eosinophilic-Oesophagitis-V1.0-FEB2022-NON-CONF.pdf (nihr.ac.uk)